Global Oral Polio Vaccines (OPV) Supply, Demand and Key Producers, 2026-2032
The global Oral Polio Vaccines (OPV) market size is expected to reach $ 282 million by 2032, rising at a market growth of 2.2% CAGR during the forecast period (2026-2032).
Oral Polio Vaccines (OPV) are preventive biological products produced from attenuated poliovirus strains through cell culture, virus harvest, clarification, stabilizer formulation, and filling, and are administered orally. The vaccine can replicate locally in the intestine and induce both humoral immunity and intestinal mucosal immunity, thereby helping prevent poliomyelitis infection and interrupt virus transmission within populations. According to the virus types included, OPV can be classified into trivalent, bivalent, monovalent, and novel oral polio vaccines. Among them, bivalent OPV and type-specific novel OPV remain important public health tools in the late stage of global polio control. Compared with injectable inactivated polio vaccines, OPV offers convenient administration, suitability for mass vaccination, strong herd-immunity effects, and high public health accessibility, making it an irreplaceable transmission-interruption tool in the global polio eradication campaign.In 2025, global Oral Polio Vaccines production reached approximately 200 million doses.The average gross profit margin of this product is 55%.
The market value of Oral Polio Vaccines comes from transmission-interruption needs in the late stage of global polio eradication, low-cost mass-coverage advantages, and public health emergency preparedness. Although more countries are strengthening IPV use in routine immunization, OPV still has unique value in inducing intestinal mucosal immunity, rapidly covering pediatric populations, and controlling localized outbreaks. China CDC documents show that the current polio immunization schedule uses a sequential arrangement of IPV and bOPV, reflecting OPV?s continuing role in maintaining herd immunity and reinforcing protection. Internationally, nOPV2 has moved from emergency use toward the WHO prequalification system, and additional manufacturers have obtained prequalification, helping improve global supply resilience and outbreak response efficiency. For manufacturers, OPV is not merely a traditional low-price vaccine, but a strategic public health product connected to national immunization programs, international organization procurement, emergency stockpiles, and the global polio eradication agenda.
The core challenges of the OPV industry come from the safety boundaries of live attenuated virus products, policy substitution pressure, and changes in demand structure. OPV contains replicating attenuated virus, which supports intestinal immunity and herd-level transmission interruption, but in areas with insufficient immunization coverage, vaccine strains may circulate for extended periods and accumulate genetic changes. As a result, global immunization strategies place greater emphasis on combined and scenario-specific use of IPV and OPV. As countries enter the post-eradication stage, routine use of conventional OPV may shrink, while demand becomes more concentrated in supplementary immunization, outbreak response, and international public health procurement. Manufacturers must continuously meet requirements for strain stability, viral titer, sterility control, low-temperature distribution, batch release, and post-marketing monitoring, while managing operating challenges related to government procurement pricing, capacity flexibility, and international certification barriers.
Downstream demand is shifting from universal routine vaccination toward sequential immunization, supplementary immunization in key regions, outbreak control, emergency stockpiling, and international organization procurement. Disease control systems focus on whether OPV can rapidly cover large target pediatric populations, effectively interrupt fecal-oral transmission chains, and coordinate smoothly with IPV-based schedules. International organizations and developing-country markets place greater emphasis on stable supply, field-use convenience, cold-chain accessibility, and mass vaccination efficiency. With the broader deployment of novel OPV, demand will increasingly emphasize type-specific virus control, genetic stability, and rapid response capability. In the future, OPV?s commercial value will not simply be reflected in unit price, but in its public health strategic position, global supply qualification, and irreplaceability within emergency response systems.
This report studies the global Oral Polio Vaccines (OPV) production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Oral Polio Vaccines (OPV) and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oral Polio Vaccines (OPV) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Oral Polio Vaccines (OPV) total production and demand, 2021-2032, (K Dose)
Global Oral Polio Vaccines (OPV) total production value, 2021-2032, (USD Million)
Global Oral Polio Vaccines (OPV) production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global Oral Polio Vaccines (OPV) consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: Oral Polio Vaccines (OPV) domestic production, consumption, key domestic manufacturers and share
Global Oral Polio Vaccines (OPV) production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global Oral Polio Vaccines (OPV) production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global Oral Polio Vaccines (OPV) production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global Oral Polio Vaccines (OPV) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, GSK, Bibcol, Serum Institute (Bilthoven Biologicals), Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oral Polio Vaccines (OPV) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Oral Polio Vaccines (OPV) Market, By Region:
1. How big is the global Oral Polio Vaccines (OPV) market?
2. What is the demand of the global Oral Polio Vaccines (OPV) market?
3. What is the year over year growth of the global Oral Polio Vaccines (OPV) market?
4. What is the production and production value of the global Oral Polio Vaccines (OPV) market?
5. Who are the key producers in the global Oral Polio Vaccines (OPV) market?
6. What are the growth factors driving the market demand?
Oral Polio Vaccines (OPV) are preventive biological products produced from attenuated poliovirus strains through cell culture, virus harvest, clarification, stabilizer formulation, and filling, and are administered orally. The vaccine can replicate locally in the intestine and induce both humoral immunity and intestinal mucosal immunity, thereby helping prevent poliomyelitis infection and interrupt virus transmission within populations. According to the virus types included, OPV can be classified into trivalent, bivalent, monovalent, and novel oral polio vaccines. Among them, bivalent OPV and type-specific novel OPV remain important public health tools in the late stage of global polio control. Compared with injectable inactivated polio vaccines, OPV offers convenient administration, suitability for mass vaccination, strong herd-immunity effects, and high public health accessibility, making it an irreplaceable transmission-interruption tool in the global polio eradication campaign.In 2025, global Oral Polio Vaccines production reached approximately 200 million doses.The average gross profit margin of this product is 55%.
The market value of Oral Polio Vaccines comes from transmission-interruption needs in the late stage of global polio eradication, low-cost mass-coverage advantages, and public health emergency preparedness. Although more countries are strengthening IPV use in routine immunization, OPV still has unique value in inducing intestinal mucosal immunity, rapidly covering pediatric populations, and controlling localized outbreaks. China CDC documents show that the current polio immunization schedule uses a sequential arrangement of IPV and bOPV, reflecting OPV?s continuing role in maintaining herd immunity and reinforcing protection. Internationally, nOPV2 has moved from emergency use toward the WHO prequalification system, and additional manufacturers have obtained prequalification, helping improve global supply resilience and outbreak response efficiency. For manufacturers, OPV is not merely a traditional low-price vaccine, but a strategic public health product connected to national immunization programs, international organization procurement, emergency stockpiles, and the global polio eradication agenda.
The core challenges of the OPV industry come from the safety boundaries of live attenuated virus products, policy substitution pressure, and changes in demand structure. OPV contains replicating attenuated virus, which supports intestinal immunity and herd-level transmission interruption, but in areas with insufficient immunization coverage, vaccine strains may circulate for extended periods and accumulate genetic changes. As a result, global immunization strategies place greater emphasis on combined and scenario-specific use of IPV and OPV. As countries enter the post-eradication stage, routine use of conventional OPV may shrink, while demand becomes more concentrated in supplementary immunization, outbreak response, and international public health procurement. Manufacturers must continuously meet requirements for strain stability, viral titer, sterility control, low-temperature distribution, batch release, and post-marketing monitoring, while managing operating challenges related to government procurement pricing, capacity flexibility, and international certification barriers.
Downstream demand is shifting from universal routine vaccination toward sequential immunization, supplementary immunization in key regions, outbreak control, emergency stockpiling, and international organization procurement. Disease control systems focus on whether OPV can rapidly cover large target pediatric populations, effectively interrupt fecal-oral transmission chains, and coordinate smoothly with IPV-based schedules. International organizations and developing-country markets place greater emphasis on stable supply, field-use convenience, cold-chain accessibility, and mass vaccination efficiency. With the broader deployment of novel OPV, demand will increasingly emphasize type-specific virus control, genetic stability, and rapid response capability. In the future, OPV?s commercial value will not simply be reflected in unit price, but in its public health strategic position, global supply qualification, and irreplaceability within emergency response systems.
This report studies the global Oral Polio Vaccines (OPV) production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Oral Polio Vaccines (OPV) and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oral Polio Vaccines (OPV) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Oral Polio Vaccines (OPV) total production and demand, 2021-2032, (K Dose)
Global Oral Polio Vaccines (OPV) total production value, 2021-2032, (USD Million)
Global Oral Polio Vaccines (OPV) production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global Oral Polio Vaccines (OPV) consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: Oral Polio Vaccines (OPV) domestic production, consumption, key domestic manufacturers and share
Global Oral Polio Vaccines (OPV) production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global Oral Polio Vaccines (OPV) production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global Oral Polio Vaccines (OPV) production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global Oral Polio Vaccines (OPV) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, GSK, Bibcol, Serum Institute (Bilthoven Biologicals), Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oral Polio Vaccines (OPV) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Oral Polio Vaccines (OPV) Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Conventional OPV
- Novel OPV
- Monovalent
- Bivalent
- Trivalent
- Oral Drops
- Sugar Pill
- Public
- Private
- Sanofi
- GSK
- Bibcol
- Serum Institute (Bilthoven Biologicals)
- Tiantan Biological
- IMBCA
- Panacea Biotec Ltd
- Bio-Med
- Halfkin Bio-Pharmaceuticals
1. How big is the global Oral Polio Vaccines (OPV) market?
2. What is the demand of the global Oral Polio Vaccines (OPV) market?
3. What is the year over year growth of the global Oral Polio Vaccines (OPV) market?
4. What is the production and production value of the global Oral Polio Vaccines (OPV) market?
5. Who are the key producers in the global Oral Polio Vaccines (OPV) market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Oral Polio Vaccines (OPV) Introduction
1.2 World Oral Polio Vaccines (OPV) Supply & Forecast
1.2.1 World Oral Polio Vaccines (OPV) Production Value (2021 & 2025 & 2032)
1.2.2 World Oral Polio Vaccines (OPV) Production (2021-2032)
1.2.3 World Oral Polio Vaccines (OPV) Pricing Trends (2021-2032)
1.3 World Oral Polio Vaccines (OPV) Production by Region (Based on Production Site)
1.3.1 World Oral Polio Vaccines (OPV) Production Value by Region (2021-2032)
1.3.2 World Oral Polio Vaccines (OPV) Production by Region (2021-2032)
1.3.3 World Oral Polio Vaccines (OPV) Average Price by Region (2021-2032)
1.3.4 North America Oral Polio Vaccines (OPV) Production (2021-2032)
1.3.5 Europe Oral Polio Vaccines (OPV) Production (2021-2032)
1.3.6 India Oral Polio Vaccines (OPV) Production (2021-2032)
1.3.7 Japan Oral Polio Vaccines (OPV) Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Oral Polio Vaccines (OPV) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Oral Polio Vaccines (OPV) Major Market Trends
2 DEMAND SUMMARY
2.1 World Oral Polio Vaccines (OPV) Demand (2021-2032)
2.2 World Oral Polio Vaccines (OPV) Consumption by Region
2.2.1 World Oral Polio Vaccines (OPV) Consumption by Region (2021-2026)
2.2.2 World Oral Polio Vaccines (OPV) Consumption Forecast by Region (2027-2032)
2.3 United States Oral Polio Vaccines (OPV) Consumption (2021-2032)
2.4 China Oral Polio Vaccines (OPV) Consumption (2021-2032)
2.5 Europe Oral Polio Vaccines (OPV) Consumption (2021-2032)
2.6 Japan Oral Polio Vaccines (OPV) Consumption (2021-2032)
2.7 South Korea Oral Polio Vaccines (OPV) Consumption (2021-2032)
2.8 ASEAN Oral Polio Vaccines (OPV) Consumption (2021-2032)
2.9 India Oral Polio Vaccines (OPV) Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Oral Polio Vaccines (OPV) Production Value by Manufacturer (2021-2026)
3.2 World Oral Polio Vaccines (OPV) Production by Manufacturer (2021-2026)
3.3 World Oral Polio Vaccines (OPV) Average Price by Manufacturer (2021-2026)
3.4 Oral Polio Vaccines (OPV) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Oral Polio Vaccines (OPV) Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Oral Polio Vaccines (OPV) in 2025
3.5.3 Global Concentration Ratios (CR8) for Oral Polio Vaccines (OPV) in 2025
3.6 Oral Polio Vaccines (OPV) Market: Overall Company Footprint Analysis
3.6.1 Oral Polio Vaccines (OPV) Market: Region Footprint
3.6.2 Oral Polio Vaccines (OPV) Market: Company Product Type Footprint
3.6.3 Oral Polio Vaccines (OPV) Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Oral Polio Vaccines (OPV) Production Value Comparison
4.1.1 United States VS China: Oral Polio Vaccines (OPV) Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Oral Polio Vaccines (OPV) Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Oral Polio Vaccines (OPV) Production Comparison
4.2.1 United States VS China: Oral Polio Vaccines (OPV) Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Oral Polio Vaccines (OPV) Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Oral Polio Vaccines (OPV) Consumption Comparison
4.3.1 United States VS China: Oral Polio Vaccines (OPV) Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Oral Polio Vaccines (OPV) Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Oral Polio Vaccines (OPV) Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Oral Polio Vaccines (OPV) Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Oral Polio Vaccines (OPV) Production Value (2021-2026)
4.4.3 United States Based Manufacturers Oral Polio Vaccines (OPV) Production (2021-2026)
4.5 China Based Oral Polio Vaccines (OPV) Manufacturers and Market Share
4.5.1 China Based Oral Polio Vaccines (OPV) Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Oral Polio Vaccines (OPV) Production Value (2021-2026)
4.5.3 China Based Manufacturers Oral Polio Vaccines (OPV) Production (2021-2026)
4.6 Rest of World Based Oral Polio Vaccines (OPV) Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Oral Polio Vaccines (OPV) Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Oral Polio Vaccines (OPV) Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Oral Polio Vaccines (OPV) Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Oral Polio Vaccines (OPV) Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Conventional OPV
5.2.2 Novel OPV
5.3 Market Segment by Type
5.3.1 World Oral Polio Vaccines (OPV) Production by Type (2021-2032)
5.3.2 World Oral Polio Vaccines (OPV) Production Value by Type (2021-2032)
5.3.3 World Oral Polio Vaccines (OPV) Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY VIRUS TYPE
6.1 World Oral Polio Vaccines (OPV) Market Size Overview by Virus Type: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Virus Type
6.2.1 Monovalent
6.2.2 Bivalent
6.2.3 Trivalent
6.3 Market Segment by Virus Type
6.3.1 World Oral Polio Vaccines (OPV) Production by Virus Type (2021-2032)
6.3.2 World Oral Polio Vaccines (OPV) Production Value by Virus Type (2021-2032)
6.3.3 World Oral Polio Vaccines (OPV) Average Price by Virus Type (2021-2032)
7 MARKET ANALYSIS BY DOSAGE FORM
7.1 World Oral Polio Vaccines (OPV) Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Dosage Form
7.2.1 Oral Drops
7.2.2 Sugar Pill
7.3 Market Segment by Dosage Form
7.3.1 World Oral Polio Vaccines (OPV) Production by Dosage Form (2021-2032)
7.3.2 World Oral Polio Vaccines (OPV) Production Value by Dosage Form (2021-2032)
7.3.3 World Oral Polio Vaccines (OPV) Average Price by Dosage Form (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Oral Polio Vaccines (OPV) Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Public
8.2.2 Private
8.3 Market Segment by Application
8.3.1 World Oral Polio Vaccines (OPV) Production by Application (2021-2032)
8.3.2 World Oral Polio Vaccines (OPV) Production Value by Application (2021-2032)
8.3.3 World Oral Polio Vaccines (OPV) Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Sanofi
9.1.1 Sanofi Details
9.1.2 Sanofi Major Business
9.1.3 Sanofi Oral Polio Vaccines (OPV) Product and Services
9.1.4 Sanofi Oral Polio Vaccines (OPV) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Sanofi Recent Developments/Updates
9.1.6 Sanofi Competitive Strengths & Weaknesses
9.2 GSK
9.2.1 GSK Details
9.2.2 GSK Major Business
9.2.3 GSK Oral Polio Vaccines (OPV) Product and Services
9.2.4 GSK Oral Polio Vaccines (OPV) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 GSK Recent Developments/Updates
9.2.6 GSK Competitive Strengths & Weaknesses
9.3 Bibcol
9.3.1 Bibcol Details
9.3.2 Bibcol Major Business
9.3.3 Bibcol Oral Polio Vaccines (OPV) Product and Services
9.3.4 Bibcol Oral Polio Vaccines (OPV) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Bibcol Recent Developments/Updates
9.3.6 Bibcol Competitive Strengths & Weaknesses
9.4 Serum Institute (Bilthoven Biologicals)
9.4.1 Serum Institute (Bilthoven Biologicals) Details
9.4.2 Serum Institute (Bilthoven Biologicals) Major Business
9.4.3 Serum Institute (Bilthoven Biologicals) Oral Polio Vaccines (OPV) Product and Services
9.4.4 Serum Institute (Bilthoven Biologicals) Oral Polio Vaccines (OPV) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Serum Institute (Bilthoven Biologicals) Recent Developments/Updates
9.4.6 Serum Institute (Bilthoven Biologicals) Competitive Strengths & Weaknesses
9.5 Tiantan Biological
9.5.1 Tiantan Biological Details
9.5.2 Tiantan Biological Major Business
9.5.3 Tiantan Biological Oral Polio Vaccines (OPV) Product and Services
9.5.4 Tiantan Biological Oral Polio Vaccines (OPV) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Tiantan Biological Recent Developments/Updates
9.5.6 Tiantan Biological Competitive Strengths & Weaknesses
9.6 IMBCA
9.6.1 IMBCA Details
9.6.2 IMBCA Major Business
9.6.3 IMBCA Oral Polio Vaccines (OPV) Product and Services
9.6.4 IMBCA Oral Polio Vaccines (OPV) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 IMBCA Recent Developments/Updates
9.6.6 IMBCA Competitive Strengths & Weaknesses
9.7 Panacea Biotec Ltd
9.7.1 Panacea Biotec Ltd Details
9.7.2 Panacea Biotec Ltd Major Business
9.7.3 Panacea Biotec Ltd Oral Polio Vaccines (OPV) Product and Services
9.7.4 Panacea Biotec Ltd Oral Polio Vaccines (OPV) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Panacea Biotec Ltd Recent Developments/Updates
9.7.6 Panacea Biotec Ltd Competitive Strengths & Weaknesses
9.8 Bio-Med
9.8.1 Bio-Med Details
9.8.2 Bio-Med Major Business
9.8.3 Bio-Med Oral Polio Vaccines (OPV) Product and Services
9.8.4 Bio-Med Oral Polio Vaccines (OPV) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Bio-Med Recent Developments/Updates
9.8.6 Bio-Med Competitive Strengths & Weaknesses
9.9 Halfkin Bio-Pharmaceuticals
9.9.1 Halfkin Bio-Pharmaceuticals Details
9.9.2 Halfkin Bio-Pharmaceuticals Major Business
9.9.3 Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Product and Services
9.9.4 Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
9.9.6 Halfkin Bio-Pharmaceuticals Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Oral Polio Vaccines (OPV) Industry Chain
10.2 Oral Polio Vaccines (OPV) Upstream Analysis
10.2.1 Oral Polio Vaccines (OPV) Core Raw Materials
10.2.2 Main Manufacturers of Oral Polio Vaccines (OPV) Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Oral Polio Vaccines (OPV) Production Mode
10.6 Oral Polio Vaccines (OPV) Procurement Model
10.7 Oral Polio Vaccines (OPV) Industry Sales Model and Sales Channels
10.7.1 Oral Polio Vaccines (OPV) Sales Model
10.7.2 Oral Polio Vaccines (OPV) Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Oral Polio Vaccines (OPV) Introduction
1.2 World Oral Polio Vaccines (OPV) Supply & Forecast
1.2.1 World Oral Polio Vaccines (OPV) Production Value (2021 & 2025 & 2032)
1.2.2 World Oral Polio Vaccines (OPV) Production (2021-2032)
1.2.3 World Oral Polio Vaccines (OPV) Pricing Trends (2021-2032)
1.3 World Oral Polio Vaccines (OPV) Production by Region (Based on Production Site)
1.3.1 World Oral Polio Vaccines (OPV) Production Value by Region (2021-2032)
1.3.2 World Oral Polio Vaccines (OPV) Production by Region (2021-2032)
1.3.3 World Oral Polio Vaccines (OPV) Average Price by Region (2021-2032)
1.3.4 North America Oral Polio Vaccines (OPV) Production (2021-2032)
1.3.5 Europe Oral Polio Vaccines (OPV) Production (2021-2032)
1.3.6 India Oral Polio Vaccines (OPV) Production (2021-2032)
1.3.7 Japan Oral Polio Vaccines (OPV) Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Oral Polio Vaccines (OPV) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Oral Polio Vaccines (OPV) Major Market Trends
2 DEMAND SUMMARY
2.1 World Oral Polio Vaccines (OPV) Demand (2021-2032)
2.2 World Oral Polio Vaccines (OPV) Consumption by Region
2.2.1 World Oral Polio Vaccines (OPV) Consumption by Region (2021-2026)
2.2.2 World Oral Polio Vaccines (OPV) Consumption Forecast by Region (2027-2032)
2.3 United States Oral Polio Vaccines (OPV) Consumption (2021-2032)
2.4 China Oral Polio Vaccines (OPV) Consumption (2021-2032)
2.5 Europe Oral Polio Vaccines (OPV) Consumption (2021-2032)
2.6 Japan Oral Polio Vaccines (OPV) Consumption (2021-2032)
2.7 South Korea Oral Polio Vaccines (OPV) Consumption (2021-2032)
2.8 ASEAN Oral Polio Vaccines (OPV) Consumption (2021-2032)
2.9 India Oral Polio Vaccines (OPV) Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Oral Polio Vaccines (OPV) Production Value by Manufacturer (2021-2026)
3.2 World Oral Polio Vaccines (OPV) Production by Manufacturer (2021-2026)
3.3 World Oral Polio Vaccines (OPV) Average Price by Manufacturer (2021-2026)
3.4 Oral Polio Vaccines (OPV) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Oral Polio Vaccines (OPV) Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Oral Polio Vaccines (OPV) in 2025
3.5.3 Global Concentration Ratios (CR8) for Oral Polio Vaccines (OPV) in 2025
3.6 Oral Polio Vaccines (OPV) Market: Overall Company Footprint Analysis
3.6.1 Oral Polio Vaccines (OPV) Market: Region Footprint
3.6.2 Oral Polio Vaccines (OPV) Market: Company Product Type Footprint
3.6.3 Oral Polio Vaccines (OPV) Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Oral Polio Vaccines (OPV) Production Value Comparison
4.1.1 United States VS China: Oral Polio Vaccines (OPV) Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Oral Polio Vaccines (OPV) Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Oral Polio Vaccines (OPV) Production Comparison
4.2.1 United States VS China: Oral Polio Vaccines (OPV) Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Oral Polio Vaccines (OPV) Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Oral Polio Vaccines (OPV) Consumption Comparison
4.3.1 United States VS China: Oral Polio Vaccines (OPV) Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Oral Polio Vaccines (OPV) Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Oral Polio Vaccines (OPV) Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Oral Polio Vaccines (OPV) Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Oral Polio Vaccines (OPV) Production Value (2021-2026)
4.4.3 United States Based Manufacturers Oral Polio Vaccines (OPV) Production (2021-2026)
4.5 China Based Oral Polio Vaccines (OPV) Manufacturers and Market Share
4.5.1 China Based Oral Polio Vaccines (OPV) Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Oral Polio Vaccines (OPV) Production Value (2021-2026)
4.5.3 China Based Manufacturers Oral Polio Vaccines (OPV) Production (2021-2026)
4.6 Rest of World Based Oral Polio Vaccines (OPV) Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Oral Polio Vaccines (OPV) Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Oral Polio Vaccines (OPV) Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Oral Polio Vaccines (OPV) Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Oral Polio Vaccines (OPV) Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Conventional OPV
5.2.2 Novel OPV
5.3 Market Segment by Type
5.3.1 World Oral Polio Vaccines (OPV) Production by Type (2021-2032)
5.3.2 World Oral Polio Vaccines (OPV) Production Value by Type (2021-2032)
5.3.3 World Oral Polio Vaccines (OPV) Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY VIRUS TYPE
6.1 World Oral Polio Vaccines (OPV) Market Size Overview by Virus Type: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Virus Type
6.2.1 Monovalent
6.2.2 Bivalent
6.2.3 Trivalent
6.3 Market Segment by Virus Type
6.3.1 World Oral Polio Vaccines (OPV) Production by Virus Type (2021-2032)
6.3.2 World Oral Polio Vaccines (OPV) Production Value by Virus Type (2021-2032)
6.3.3 World Oral Polio Vaccines (OPV) Average Price by Virus Type (2021-2032)
7 MARKET ANALYSIS BY DOSAGE FORM
7.1 World Oral Polio Vaccines (OPV) Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Dosage Form
7.2.1 Oral Drops
7.2.2 Sugar Pill
7.3 Market Segment by Dosage Form
7.3.1 World Oral Polio Vaccines (OPV) Production by Dosage Form (2021-2032)
7.3.2 World Oral Polio Vaccines (OPV) Production Value by Dosage Form (2021-2032)
7.3.3 World Oral Polio Vaccines (OPV) Average Price by Dosage Form (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Oral Polio Vaccines (OPV) Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Public
8.2.2 Private
8.3 Market Segment by Application
8.3.1 World Oral Polio Vaccines (OPV) Production by Application (2021-2032)
8.3.2 World Oral Polio Vaccines (OPV) Production Value by Application (2021-2032)
8.3.3 World Oral Polio Vaccines (OPV) Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Sanofi
9.1.1 Sanofi Details
9.1.2 Sanofi Major Business
9.1.3 Sanofi Oral Polio Vaccines (OPV) Product and Services
9.1.4 Sanofi Oral Polio Vaccines (OPV) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Sanofi Recent Developments/Updates
9.1.6 Sanofi Competitive Strengths & Weaknesses
9.2 GSK
9.2.1 GSK Details
9.2.2 GSK Major Business
9.2.3 GSK Oral Polio Vaccines (OPV) Product and Services
9.2.4 GSK Oral Polio Vaccines (OPV) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 GSK Recent Developments/Updates
9.2.6 GSK Competitive Strengths & Weaknesses
9.3 Bibcol
9.3.1 Bibcol Details
9.3.2 Bibcol Major Business
9.3.3 Bibcol Oral Polio Vaccines (OPV) Product and Services
9.3.4 Bibcol Oral Polio Vaccines (OPV) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Bibcol Recent Developments/Updates
9.3.6 Bibcol Competitive Strengths & Weaknesses
9.4 Serum Institute (Bilthoven Biologicals)
9.4.1 Serum Institute (Bilthoven Biologicals) Details
9.4.2 Serum Institute (Bilthoven Biologicals) Major Business
9.4.3 Serum Institute (Bilthoven Biologicals) Oral Polio Vaccines (OPV) Product and Services
9.4.4 Serum Institute (Bilthoven Biologicals) Oral Polio Vaccines (OPV) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Serum Institute (Bilthoven Biologicals) Recent Developments/Updates
9.4.6 Serum Institute (Bilthoven Biologicals) Competitive Strengths & Weaknesses
9.5 Tiantan Biological
9.5.1 Tiantan Biological Details
9.5.2 Tiantan Biological Major Business
9.5.3 Tiantan Biological Oral Polio Vaccines (OPV) Product and Services
9.5.4 Tiantan Biological Oral Polio Vaccines (OPV) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Tiantan Biological Recent Developments/Updates
9.5.6 Tiantan Biological Competitive Strengths & Weaknesses
9.6 IMBCA
9.6.1 IMBCA Details
9.6.2 IMBCA Major Business
9.6.3 IMBCA Oral Polio Vaccines (OPV) Product and Services
9.6.4 IMBCA Oral Polio Vaccines (OPV) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 IMBCA Recent Developments/Updates
9.6.6 IMBCA Competitive Strengths & Weaknesses
9.7 Panacea Biotec Ltd
9.7.1 Panacea Biotec Ltd Details
9.7.2 Panacea Biotec Ltd Major Business
9.7.3 Panacea Biotec Ltd Oral Polio Vaccines (OPV) Product and Services
9.7.4 Panacea Biotec Ltd Oral Polio Vaccines (OPV) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Panacea Biotec Ltd Recent Developments/Updates
9.7.6 Panacea Biotec Ltd Competitive Strengths & Weaknesses
9.8 Bio-Med
9.8.1 Bio-Med Details
9.8.2 Bio-Med Major Business
9.8.3 Bio-Med Oral Polio Vaccines (OPV) Product and Services
9.8.4 Bio-Med Oral Polio Vaccines (OPV) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Bio-Med Recent Developments/Updates
9.8.6 Bio-Med Competitive Strengths & Weaknesses
9.9 Halfkin Bio-Pharmaceuticals
9.9.1 Halfkin Bio-Pharmaceuticals Details
9.9.2 Halfkin Bio-Pharmaceuticals Major Business
9.9.3 Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Product and Services
9.9.4 Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
9.9.6 Halfkin Bio-Pharmaceuticals Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Oral Polio Vaccines (OPV) Industry Chain
10.2 Oral Polio Vaccines (OPV) Upstream Analysis
10.2.1 Oral Polio Vaccines (OPV) Core Raw Materials
10.2.2 Main Manufacturers of Oral Polio Vaccines (OPV) Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Oral Polio Vaccines (OPV) Production Mode
10.6 Oral Polio Vaccines (OPV) Procurement Model
10.7 Oral Polio Vaccines (OPV) Industry Sales Model and Sales Channels
10.7.1 Oral Polio Vaccines (OPV) Sales Model
10.7.2 Oral Polio Vaccines (OPV) Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Oral Polio Vaccines (OPV) Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Oral Polio Vaccines (OPV) Production Value by Region (2021-2026) & (USD Million)
Table 3. World Oral Polio Vaccines (OPV) Production Value by Region (2027-2032) & (USD Million)
Table 4. World Oral Polio Vaccines (OPV) Production Value Market Share by Region (2021-2026)
Table 5. World Oral Polio Vaccines (OPV) Production Value Market Share by Region (2027-2032)
Table 6. World Oral Polio Vaccines (OPV) Production by Region (2021-2026) & (K Dose)
Table 7. World Oral Polio Vaccines (OPV) Production by Region (2027-2032) & (K Dose)
Table 8. World Oral Polio Vaccines (OPV) Production Market Share by Region (2021-2026)
Table 9. World Oral Polio Vaccines (OPV) Production Market Share by Region (2027-2032)
Table 10. World Oral Polio Vaccines (OPV) Average Price by Region (2021-2026) & (US$/Dose)
Table 11. World Oral Polio Vaccines (OPV) Average Price by Region (2027-2032) & (US$/Dose)
Table 12. Oral Polio Vaccines (OPV) Major Market Trends
Table 13. World Oral Polio Vaccines (OPV) Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World Oral Polio Vaccines (OPV) Consumption by Region (2021-2026) & (K Dose)
Table 15. World Oral Polio Vaccines (OPV) Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World Oral Polio Vaccines (OPV) Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Oral Polio Vaccines (OPV) Producers in 2025
Table 18. World Oral Polio Vaccines (OPV) Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key Oral Polio Vaccines (OPV) Producers in 2025
Table 20. World Oral Polio Vaccines (OPV) Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 21. Global Oral Polio Vaccines (OPV) Company Evaluation Quadrant
Table 22. World Oral Polio Vaccines (OPV) Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Oral Polio Vaccines (OPV) Production Site of Key Manufacturer
Table 24. Oral Polio Vaccines (OPV) Market: Company Product Type Footprint
Table 25. Oral Polio Vaccines (OPV) Market: Company Product Application Footprint
Table 26. Oral Polio Vaccines (OPV) Competitive Factors
Table 27. Oral Polio Vaccines (OPV) New Entrant and Capacity Expansion Plans
Table 28. Oral Polio Vaccines (OPV) Mergers & Acquisitions Activity
Table 29. United States VS China Oral Polio Vaccines (OPV) Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Oral Polio Vaccines (OPV) Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China Oral Polio Vaccines (OPV) Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based Oral Polio Vaccines (OPV) Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Oral Polio Vaccines (OPV) Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Oral Polio Vaccines (OPV) Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Oral Polio Vaccines (OPV) Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers Oral Polio Vaccines (OPV) Production Market Share (2021-2026)
Table 37. China Based Oral Polio Vaccines (OPV) Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Oral Polio Vaccines (OPV) Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Oral Polio Vaccines (OPV) Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Oral Polio Vaccines (OPV) Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers Oral Polio Vaccines (OPV) Production Market Share (2021-2026)
Table 42. Rest of World Based Oral Polio Vaccines (OPV) Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Oral Polio Vaccines (OPV) Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Oral Polio Vaccines (OPV) Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Oral Polio Vaccines (OPV) Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers Oral Polio Vaccines (OPV) Production Market Share (2021-2026)
Table 47. World Oral Polio Vaccines (OPV) Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Oral Polio Vaccines (OPV) Production by Type (2021-2026) & (K Dose)
Table 49. World Oral Polio Vaccines (OPV) Production by Type (2027-2032) & (K Dose)
Table 50. World Oral Polio Vaccines (OPV) Production Value by Type (2021-2026) & (USD Million)
Table 51. World Oral Polio Vaccines (OPV) Production Value by Type (2027-2032) & (USD Million)
Table 52. World Oral Polio Vaccines (OPV) Average Price by Type (2021-2026) & (US$/Dose)
Table 53. World Oral Polio Vaccines (OPV) Average Price by Type (2027-2032) & (US$/Dose)
Table 54. World Oral Polio Vaccines (OPV) Production Value by Virus Type, (USD Million), 2021 & 2025 & 2032
Table 55. World Oral Polio Vaccines (OPV) Production by Virus Type (2021-2026) & (K Dose)
Table 56. World Oral Polio Vaccines (OPV) Production by Virus Type (2027-2032) & (K Dose)
Table 57. World Oral Polio Vaccines (OPV) Production Value by Virus Type (2021-2026) & (USD Million)
Table 58. World Oral Polio Vaccines (OPV) Production Value by Virus Type (2027-2032) & (USD Million)
Table 59. World Oral Polio Vaccines (OPV) Average Price by Virus Type (2021-2026) & (US$/Dose)
Table 60. World Oral Polio Vaccines (OPV) Average Price by Virus Type (2027-2032) & (US$/Dose)
Table 61. World Oral Polio Vaccines (OPV) Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 62. World Oral Polio Vaccines (OPV) Production by Dosage Form (2021-2026) & (K Dose)
Table 63. World Oral Polio Vaccines (OPV) Production by Dosage Form (2027-2032) & (K Dose)
Table 64. World Oral Polio Vaccines (OPV) Production Value by Dosage Form (2021-2026) & (USD Million)
Table 65. World Oral Polio Vaccines (OPV) Production Value by Dosage Form (2027-2032) & (USD Million)
Table 66. World Oral Polio Vaccines (OPV) Average Price by Dosage Form (2021-2026) & (US$/Dose)
Table 67. World Oral Polio Vaccines (OPV) Average Price by Dosage Form (2027-2032) & (US$/Dose)
Table 68. World Oral Polio Vaccines (OPV) Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Oral Polio Vaccines (OPV) Production by Application (2021-2026) & (K Dose)
Table 70. World Oral Polio Vaccines (OPV) Production by Application (2027-2032) & (K Dose)
Table 71. World Oral Polio Vaccines (OPV) Production Value by Application (2021-2026) & (USD Million)
Table 72. World Oral Polio Vaccines (OPV) Production Value by Application (2027-2032) & (USD Million)
Table 73. World Oral Polio Vaccines (OPV) Average Price by Application (2021-2026) & (US$/Dose)
Table 74. World Oral Polio Vaccines (OPV) Average Price by Application (2027-2032) & (US$/Dose)
Table 75. Sanofi Basic Information, Manufacturing Base and Competitors
Table 76. Sanofi Major Business
Table 77. Sanofi Oral Polio Vaccines (OPV) Product and Services
Table 78. Sanofi Oral Polio Vaccines (OPV) Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Sanofi Recent Developments/Updates
Table 80. Sanofi Competitive Strengths & Weaknesses
Table 81. GSK Basic Information, Manufacturing Base and Competitors
Table 82. GSK Major Business
Table 83. GSK Oral Polio Vaccines (OPV) Product and Services
Table 84. GSK Oral Polio Vaccines (OPV) Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. GSK Recent Developments/Updates
Table 86. GSK Competitive Strengths & Weaknesses
Table 87. Bibcol Basic Information, Manufacturing Base and Competitors
Table 88. Bibcol Major Business
Table 89. Bibcol Oral Polio Vaccines (OPV) Product and Services
Table 90. Bibcol Oral Polio Vaccines (OPV) Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Bibcol Recent Developments/Updates
Table 92. Bibcol Competitive Strengths & Weaknesses
Table 93. Serum?Institute?(Bilthoven?Biologicals) Basic Information, Manufacturing Base and Competitors
Table 94. Serum?Institute?(Bilthoven?Biologicals) Major Business
Table 95. Serum?Institute?(Bilthoven?Biologicals) Oral Polio Vaccines (OPV) Product and Services
Table 96. Serum?Institute?(Bilthoven?Biologicals) Oral Polio Vaccines (OPV) Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Serum?Institute?(Bilthoven?Biologicals) Recent Developments/Updates
Table 98. Serum?Institute?(Bilthoven?Biologicals) Competitive Strengths & Weaknesses
Table 99. Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 100. Tiantan Biological Major Business
Table 101. Tiantan Biological Oral Polio Vaccines (OPV) Product and Services
Table 102. Tiantan Biological Oral Polio Vaccines (OPV) Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Tiantan Biological Recent Developments/Updates
Table 104. Tiantan Biological Competitive Strengths & Weaknesses
Table 105. IMBCA Basic Information, Manufacturing Base and Competitors
Table 106. IMBCA Major Business
Table 107. IMBCA Oral Polio Vaccines (OPV) Product and Services
Table 108. IMBCA Oral Polio Vaccines (OPV) Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. IMBCA Recent Developments/Updates
Table 110. IMBCA Competitive Strengths & Weaknesses
Table 111. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
Table 112. Panacea Biotec Ltd Major Business
Table 113. Panacea Biotec Ltd Oral Polio Vaccines (OPV) Product and Services
Table 114. Panacea Biotec Ltd Oral Polio Vaccines (OPV) Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Panacea Biotec Ltd Recent Developments/Updates
Table 116. Panacea Biotec Ltd Competitive Strengths & Weaknesses
Table 117. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 118. Bio-Med Major Business
Table 119. Bio-Med Oral Polio Vaccines (OPV) Product and Services
Table 120. Bio-Med Oral Polio Vaccines (OPV) Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Bio-Med Recent Developments/Updates
Table 122. Bio-Med Competitive Strengths & Weaknesses
Table 123. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 124. Halfkin Bio-Pharmaceuticals Major Business
Table 125. Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Product and Services
Table 126. Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 128. Halfkin Bio-Pharmaceuticals Competitive Strengths & Weaknesses
Table 129. Global Key Players of Oral Polio Vaccines (OPV) Upstream (Raw Materials)
Table 130. Global Oral Polio Vaccines (OPV) Typical Customers
Table 131. Oral Polio Vaccines (OPV) Typical Distributors
Table 1. World Oral Polio Vaccines (OPV) Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Oral Polio Vaccines (OPV) Production Value by Region (2021-2026) & (USD Million)
Table 3. World Oral Polio Vaccines (OPV) Production Value by Region (2027-2032) & (USD Million)
Table 4. World Oral Polio Vaccines (OPV) Production Value Market Share by Region (2021-2026)
Table 5. World Oral Polio Vaccines (OPV) Production Value Market Share by Region (2027-2032)
Table 6. World Oral Polio Vaccines (OPV) Production by Region (2021-2026) & (K Dose)
Table 7. World Oral Polio Vaccines (OPV) Production by Region (2027-2032) & (K Dose)
Table 8. World Oral Polio Vaccines (OPV) Production Market Share by Region (2021-2026)
Table 9. World Oral Polio Vaccines (OPV) Production Market Share by Region (2027-2032)
Table 10. World Oral Polio Vaccines (OPV) Average Price by Region (2021-2026) & (US$/Dose)
Table 11. World Oral Polio Vaccines (OPV) Average Price by Region (2027-2032) & (US$/Dose)
Table 12. Oral Polio Vaccines (OPV) Major Market Trends
Table 13. World Oral Polio Vaccines (OPV) Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World Oral Polio Vaccines (OPV) Consumption by Region (2021-2026) & (K Dose)
Table 15. World Oral Polio Vaccines (OPV) Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World Oral Polio Vaccines (OPV) Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Oral Polio Vaccines (OPV) Producers in 2025
Table 18. World Oral Polio Vaccines (OPV) Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key Oral Polio Vaccines (OPV) Producers in 2025
Table 20. World Oral Polio Vaccines (OPV) Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 21. Global Oral Polio Vaccines (OPV) Company Evaluation Quadrant
Table 22. World Oral Polio Vaccines (OPV) Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Oral Polio Vaccines (OPV) Production Site of Key Manufacturer
Table 24. Oral Polio Vaccines (OPV) Market: Company Product Type Footprint
Table 25. Oral Polio Vaccines (OPV) Market: Company Product Application Footprint
Table 26. Oral Polio Vaccines (OPV) Competitive Factors
Table 27. Oral Polio Vaccines (OPV) New Entrant and Capacity Expansion Plans
Table 28. Oral Polio Vaccines (OPV) Mergers & Acquisitions Activity
Table 29. United States VS China Oral Polio Vaccines (OPV) Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Oral Polio Vaccines (OPV) Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China Oral Polio Vaccines (OPV) Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based Oral Polio Vaccines (OPV) Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Oral Polio Vaccines (OPV) Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Oral Polio Vaccines (OPV) Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Oral Polio Vaccines (OPV) Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers Oral Polio Vaccines (OPV) Production Market Share (2021-2026)
Table 37. China Based Oral Polio Vaccines (OPV) Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Oral Polio Vaccines (OPV) Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Oral Polio Vaccines (OPV) Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Oral Polio Vaccines (OPV) Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers Oral Polio Vaccines (OPV) Production Market Share (2021-2026)
Table 42. Rest of World Based Oral Polio Vaccines (OPV) Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Oral Polio Vaccines (OPV) Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Oral Polio Vaccines (OPV) Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Oral Polio Vaccines (OPV) Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers Oral Polio Vaccines (OPV) Production Market Share (2021-2026)
Table 47. World Oral Polio Vaccines (OPV) Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Oral Polio Vaccines (OPV) Production by Type (2021-2026) & (K Dose)
Table 49. World Oral Polio Vaccines (OPV) Production by Type (2027-2032) & (K Dose)
Table 50. World Oral Polio Vaccines (OPV) Production Value by Type (2021-2026) & (USD Million)
Table 51. World Oral Polio Vaccines (OPV) Production Value by Type (2027-2032) & (USD Million)
Table 52. World Oral Polio Vaccines (OPV) Average Price by Type (2021-2026) & (US$/Dose)
Table 53. World Oral Polio Vaccines (OPV) Average Price by Type (2027-2032) & (US$/Dose)
Table 54. World Oral Polio Vaccines (OPV) Production Value by Virus Type, (USD Million), 2021 & 2025 & 2032
Table 55. World Oral Polio Vaccines (OPV) Production by Virus Type (2021-2026) & (K Dose)
Table 56. World Oral Polio Vaccines (OPV) Production by Virus Type (2027-2032) & (K Dose)
Table 57. World Oral Polio Vaccines (OPV) Production Value by Virus Type (2021-2026) & (USD Million)
Table 58. World Oral Polio Vaccines (OPV) Production Value by Virus Type (2027-2032) & (USD Million)
Table 59. World Oral Polio Vaccines (OPV) Average Price by Virus Type (2021-2026) & (US$/Dose)
Table 60. World Oral Polio Vaccines (OPV) Average Price by Virus Type (2027-2032) & (US$/Dose)
Table 61. World Oral Polio Vaccines (OPV) Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 62. World Oral Polio Vaccines (OPV) Production by Dosage Form (2021-2026) & (K Dose)
Table 63. World Oral Polio Vaccines (OPV) Production by Dosage Form (2027-2032) & (K Dose)
Table 64. World Oral Polio Vaccines (OPV) Production Value by Dosage Form (2021-2026) & (USD Million)
Table 65. World Oral Polio Vaccines (OPV) Production Value by Dosage Form (2027-2032) & (USD Million)
Table 66. World Oral Polio Vaccines (OPV) Average Price by Dosage Form (2021-2026) & (US$/Dose)
Table 67. World Oral Polio Vaccines (OPV) Average Price by Dosage Form (2027-2032) & (US$/Dose)
Table 68. World Oral Polio Vaccines (OPV) Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Oral Polio Vaccines (OPV) Production by Application (2021-2026) & (K Dose)
Table 70. World Oral Polio Vaccines (OPV) Production by Application (2027-2032) & (K Dose)
Table 71. World Oral Polio Vaccines (OPV) Production Value by Application (2021-2026) & (USD Million)
Table 72. World Oral Polio Vaccines (OPV) Production Value by Application (2027-2032) & (USD Million)
Table 73. World Oral Polio Vaccines (OPV) Average Price by Application (2021-2026) & (US$/Dose)
Table 74. World Oral Polio Vaccines (OPV) Average Price by Application (2027-2032) & (US$/Dose)
Table 75. Sanofi Basic Information, Manufacturing Base and Competitors
Table 76. Sanofi Major Business
Table 77. Sanofi Oral Polio Vaccines (OPV) Product and Services
Table 78. Sanofi Oral Polio Vaccines (OPV) Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Sanofi Recent Developments/Updates
Table 80. Sanofi Competitive Strengths & Weaknesses
Table 81. GSK Basic Information, Manufacturing Base and Competitors
Table 82. GSK Major Business
Table 83. GSK Oral Polio Vaccines (OPV) Product and Services
Table 84. GSK Oral Polio Vaccines (OPV) Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. GSK Recent Developments/Updates
Table 86. GSK Competitive Strengths & Weaknesses
Table 87. Bibcol Basic Information, Manufacturing Base and Competitors
Table 88. Bibcol Major Business
Table 89. Bibcol Oral Polio Vaccines (OPV) Product and Services
Table 90. Bibcol Oral Polio Vaccines (OPV) Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Bibcol Recent Developments/Updates
Table 92. Bibcol Competitive Strengths & Weaknesses
Table 93. Serum?Institute?(Bilthoven?Biologicals) Basic Information, Manufacturing Base and Competitors
Table 94. Serum?Institute?(Bilthoven?Biologicals) Major Business
Table 95. Serum?Institute?(Bilthoven?Biologicals) Oral Polio Vaccines (OPV) Product and Services
Table 96. Serum?Institute?(Bilthoven?Biologicals) Oral Polio Vaccines (OPV) Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Serum?Institute?(Bilthoven?Biologicals) Recent Developments/Updates
Table 98. Serum?Institute?(Bilthoven?Biologicals) Competitive Strengths & Weaknesses
Table 99. Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 100. Tiantan Biological Major Business
Table 101. Tiantan Biological Oral Polio Vaccines (OPV) Product and Services
Table 102. Tiantan Biological Oral Polio Vaccines (OPV) Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Tiantan Biological Recent Developments/Updates
Table 104. Tiantan Biological Competitive Strengths & Weaknesses
Table 105. IMBCA Basic Information, Manufacturing Base and Competitors
Table 106. IMBCA Major Business
Table 107. IMBCA Oral Polio Vaccines (OPV) Product and Services
Table 108. IMBCA Oral Polio Vaccines (OPV) Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. IMBCA Recent Developments/Updates
Table 110. IMBCA Competitive Strengths & Weaknesses
Table 111. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
Table 112. Panacea Biotec Ltd Major Business
Table 113. Panacea Biotec Ltd Oral Polio Vaccines (OPV) Product and Services
Table 114. Panacea Biotec Ltd Oral Polio Vaccines (OPV) Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Panacea Biotec Ltd Recent Developments/Updates
Table 116. Panacea Biotec Ltd Competitive Strengths & Weaknesses
Table 117. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 118. Bio-Med Major Business
Table 119. Bio-Med Oral Polio Vaccines (OPV) Product and Services
Table 120. Bio-Med Oral Polio Vaccines (OPV) Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Bio-Med Recent Developments/Updates
Table 122. Bio-Med Competitive Strengths & Weaknesses
Table 123. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 124. Halfkin Bio-Pharmaceuticals Major Business
Table 125. Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Product and Services
Table 126. Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 128. Halfkin Bio-Pharmaceuticals Competitive Strengths & Weaknesses
Table 129. Global Key Players of Oral Polio Vaccines (OPV) Upstream (Raw Materials)
Table 130. Global Oral Polio Vaccines (OPV) Typical Customers
Table 131. Oral Polio Vaccines (OPV) Typical Distributors
LIST OF FIGURES
Figure 1. Oral Polio Vaccines (OPV) Picture
Figure 2. World Oral Polio Vaccines (OPV) Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Oral Polio Vaccines (OPV) Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Oral Polio Vaccines (OPV) Production (2021-2032) & (K Dose)
Figure 5. World Oral Polio Vaccines (OPV) Average Price (2021-2032) & (US$/Dose)
Figure 6. World Oral Polio Vaccines (OPV) Production Value Market Share by Region (2021-2032)
Figure 7. World Oral Polio Vaccines (OPV) Production Market Share by Region (2021-2032)
Figure 8. North America Oral Polio Vaccines (OPV) Production (2021-2032) & (K Dose)
Figure 9. Europe Oral Polio Vaccines (OPV) Production (2021-2032) & (K Dose)
Figure 10. India Oral Polio Vaccines (OPV) Production (2021-2032) & (K Dose)
Figure 11. Japan Oral Polio Vaccines (OPV) Production (2021-2032) & (K Dose)
Figure 12. Oral Polio Vaccines (OPV) Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Oral Polio Vaccines (OPV) Consumption (2021-2032) & (K Dose)
Figure 15. World Oral Polio Vaccines (OPV) Consumption Market Share by Region (2021-2032)
Figure 16. United States Oral Polio Vaccines (OPV) Consumption (2021-2032) & (K Dose)
Figure 17. China Oral Polio Vaccines (OPV) Consumption (2021-2032) & (K Dose)
Figure 18. Europe Oral Polio Vaccines (OPV) Consumption (2021-2032) & (K Dose)
Figure 19. Japan Oral Polio Vaccines (OPV) Consumption (2021-2032) & (K Dose)
Figure 20. South Korea Oral Polio Vaccines (OPV) Consumption (2021-2032) & (K Dose)
Figure 21. ASEAN Oral Polio Vaccines (OPV) Consumption (2021-2032) & (K Dose)
Figure 22. India Oral Polio Vaccines (OPV) Consumption (2021-2032) & (K Dose)
Figure 23. Producer Shipments of Oral Polio Vaccines (OPV) by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Oral Polio Vaccines (OPV) Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Oral Polio Vaccines (OPV) Markets in 2025
Figure 26. United States VS China: Oral Polio Vaccines (OPV) Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Oral Polio Vaccines (OPV) Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Oral Polio Vaccines (OPV) Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Oral Polio Vaccines (OPV) Production Market Share 2025
Figure 30. China Based Manufacturers Oral Polio Vaccines (OPV) Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Oral Polio Vaccines (OPV) Production Market Share 2025
Figure 32. World Oral Polio Vaccines (OPV) Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Oral Polio Vaccines (OPV) Production Value Market Share by Type in 2025
Figure 34. Conventional OPV
Figure 35. Novel OPV
Figure 36. World Oral Polio Vaccines (OPV) Production Market Share by Type (2021-2032)
Figure 37. World Oral Polio Vaccines (OPV) Production Value Market Share by Type (2021-2032)
Figure 38. World Oral Polio Vaccines (OPV) Average Price by Type (2021-2032) & (US$/Dose)
Figure 39. World Oral Polio Vaccines (OPV) Production Value by Virus Type, (USD Million), 2021 & 2025 & 2032
Figure 40. World Oral Polio Vaccines (OPV) Production Value Market Share by Virus Type in 2025
Figure 41. Monovalent
Figure 42. Bivalent
Figure 43. Trivalent
Figure 44. World Oral Polio Vaccines (OPV) Production Market Share by Virus Type (2021-2032)
Figure 45. World Oral Polio Vaccines (OPV) Production Value Market Share by Virus Type (2021-2032)
Figure 46. World Oral Polio Vaccines (OPV) Average Price by Virus Type (2021-2032) & (US$/Dose)
Figure 47. World Oral Polio Vaccines (OPV) Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 48. World Oral Polio Vaccines (OPV) Production Value Market Share by Dosage Form in 2025
Figure 49. Oral Drops
Figure 50. Sugar Pill
Figure 51. World Oral Polio Vaccines (OPV) Production Market Share by Dosage Form (2021-2032)
Figure 52. World Oral Polio Vaccines (OPV) Production Value Market Share by Dosage Form (2021-2032)
Figure 53. World Oral Polio Vaccines (OPV) Average Price by Dosage Form (2021-2032) & (US$/Dose)
Figure 54. World Oral Polio Vaccines (OPV) Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 55. World Oral Polio Vaccines (OPV) Production Value Market Share by Application in 2025
Figure 56. Public
Figure 57. Private
Figure 58. World Oral Polio Vaccines (OPV) Production Market Share by Application (2021-2032)
Figure 59. World Oral Polio Vaccines (OPV) Production Value Market Share by Application (2021-2032)
Figure 60. World Oral Polio Vaccines (OPV) Average Price by Application (2021-2032) & (US$/Dose)
Figure 61. Oral Polio Vaccines (OPV) Industry Chain
Figure 62. Oral Polio Vaccines (OPV) Procurement Model
Figure 63. Oral Polio Vaccines (OPV) Sales Model
Figure 64. Oral Polio Vaccines (OPV) Sales Channels, Direct Sales, and Distribution
Figure 65. Methodology
Figure 66. Research Process and Data Source
Figure 1. Oral Polio Vaccines (OPV) Picture
Figure 2. World Oral Polio Vaccines (OPV) Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Oral Polio Vaccines (OPV) Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Oral Polio Vaccines (OPV) Production (2021-2032) & (K Dose)
Figure 5. World Oral Polio Vaccines (OPV) Average Price (2021-2032) & (US$/Dose)
Figure 6. World Oral Polio Vaccines (OPV) Production Value Market Share by Region (2021-2032)
Figure 7. World Oral Polio Vaccines (OPV) Production Market Share by Region (2021-2032)
Figure 8. North America Oral Polio Vaccines (OPV) Production (2021-2032) & (K Dose)
Figure 9. Europe Oral Polio Vaccines (OPV) Production (2021-2032) & (K Dose)
Figure 10. India Oral Polio Vaccines (OPV) Production (2021-2032) & (K Dose)
Figure 11. Japan Oral Polio Vaccines (OPV) Production (2021-2032) & (K Dose)
Figure 12. Oral Polio Vaccines (OPV) Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Oral Polio Vaccines (OPV) Consumption (2021-2032) & (K Dose)
Figure 15. World Oral Polio Vaccines (OPV) Consumption Market Share by Region (2021-2032)
Figure 16. United States Oral Polio Vaccines (OPV) Consumption (2021-2032) & (K Dose)
Figure 17. China Oral Polio Vaccines (OPV) Consumption (2021-2032) & (K Dose)
Figure 18. Europe Oral Polio Vaccines (OPV) Consumption (2021-2032) & (K Dose)
Figure 19. Japan Oral Polio Vaccines (OPV) Consumption (2021-2032) & (K Dose)
Figure 20. South Korea Oral Polio Vaccines (OPV) Consumption (2021-2032) & (K Dose)
Figure 21. ASEAN Oral Polio Vaccines (OPV) Consumption (2021-2032) & (K Dose)
Figure 22. India Oral Polio Vaccines (OPV) Consumption (2021-2032) & (K Dose)
Figure 23. Producer Shipments of Oral Polio Vaccines (OPV) by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Oral Polio Vaccines (OPV) Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Oral Polio Vaccines (OPV) Markets in 2025
Figure 26. United States VS China: Oral Polio Vaccines (OPV) Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Oral Polio Vaccines (OPV) Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Oral Polio Vaccines (OPV) Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Oral Polio Vaccines (OPV) Production Market Share 2025
Figure 30. China Based Manufacturers Oral Polio Vaccines (OPV) Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Oral Polio Vaccines (OPV) Production Market Share 2025
Figure 32. World Oral Polio Vaccines (OPV) Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Oral Polio Vaccines (OPV) Production Value Market Share by Type in 2025
Figure 34. Conventional OPV
Figure 35. Novel OPV
Figure 36. World Oral Polio Vaccines (OPV) Production Market Share by Type (2021-2032)
Figure 37. World Oral Polio Vaccines (OPV) Production Value Market Share by Type (2021-2032)
Figure 38. World Oral Polio Vaccines (OPV) Average Price by Type (2021-2032) & (US$/Dose)
Figure 39. World Oral Polio Vaccines (OPV) Production Value by Virus Type, (USD Million), 2021 & 2025 & 2032
Figure 40. World Oral Polio Vaccines (OPV) Production Value Market Share by Virus Type in 2025
Figure 41. Monovalent
Figure 42. Bivalent
Figure 43. Trivalent
Figure 44. World Oral Polio Vaccines (OPV) Production Market Share by Virus Type (2021-2032)
Figure 45. World Oral Polio Vaccines (OPV) Production Value Market Share by Virus Type (2021-2032)
Figure 46. World Oral Polio Vaccines (OPV) Average Price by Virus Type (2021-2032) & (US$/Dose)
Figure 47. World Oral Polio Vaccines (OPV) Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 48. World Oral Polio Vaccines (OPV) Production Value Market Share by Dosage Form in 2025
Figure 49. Oral Drops
Figure 50. Sugar Pill
Figure 51. World Oral Polio Vaccines (OPV) Production Market Share by Dosage Form (2021-2032)
Figure 52. World Oral Polio Vaccines (OPV) Production Value Market Share by Dosage Form (2021-2032)
Figure 53. World Oral Polio Vaccines (OPV) Average Price by Dosage Form (2021-2032) & (US$/Dose)
Figure 54. World Oral Polio Vaccines (OPV) Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 55. World Oral Polio Vaccines (OPV) Production Value Market Share by Application in 2025
Figure 56. Public
Figure 57. Private
Figure 58. World Oral Polio Vaccines (OPV) Production Market Share by Application (2021-2032)
Figure 59. World Oral Polio Vaccines (OPV) Production Value Market Share by Application (2021-2032)
Figure 60. World Oral Polio Vaccines (OPV) Average Price by Application (2021-2032) & (US$/Dose)
Figure 61. Oral Polio Vaccines (OPV) Industry Chain
Figure 62. Oral Polio Vaccines (OPV) Procurement Model
Figure 63. Oral Polio Vaccines (OPV) Sales Model
Figure 64. Oral Polio Vaccines (OPV) Sales Channels, Direct Sales, and Distribution
Figure 65. Methodology
Figure 66. Research Process and Data Source
